Baudax Bio, Inc.
BXRXQ
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 93.38% | 2.07% | 189.03% | -131.43% | -72.18% |
| Total Depreciation and Amortization | 1,355.56% | -93.33% | -78.57% | -11.11% | -80.43% |
| Total Amortization of Deferred Charges | -- | -- | -- | -89.91% | -- |
| Total Other Non-Cash Items | -113.97% | 140.20% | -402.65% | 114.12% | 377.06% |
| Change in Net Operating Assets | 323.47% | 232.12% | -54.19% | -3.48% | 145.79% |
| Cash from Operations | 37.94% | 70.93% | 31.77% | 70.09% | 69.06% |
| Capital Expenditure | -- | -- | -- | 100.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -100.00% |
| Cash from Investing | -- | 810.00% | -- | -100.00% | -100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 34.05% | -763.31% | -- | -- | -- |
| Issuance of Common Stock | -62.22% | 109.60% | -52.30% | 25.68% | -- |
| Repurchase of Common Stock | -- | -- | -- | 100.00% | 98.72% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 53.00% | 82.07% | -53.85% | -- | -- |
| Cash from Financing | -68.07% | 128.11% | -64.59% | -9.27% | 5,644.87% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -90.51% | 90.51% | -- | -- |
| Net Change in Cash | -340.96% | 62.21% | 66.64% | -134.67% | 104.11% |